Chimeric antigen receptor-modified T-cell therapy for bone marrow and skin relapse Philadelphia chromosome-like acute lymphoblastic leukemia: A case report

RATIONALE: Chimeric antigen receptor-modified T-cell (CART) therapy has revolutionized the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). However, the capacity of CART therapy has not yet been fully elucidated. PATIENT CONCERNS: An 18-year-old Chinese ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mianzeng, Liu, Bingcheng, Wang, Ying, Liu, Yuntao, Gong, Xiaoyuan, Gong, Benfa, Xu, Yingxi, Mi, Yingchang, Wang, Min, Wang, Jianxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440224/
https://www.ncbi.nlm.nih.gov/pubmed/32358340
http://dx.doi.org/10.1097/MD.0000000000018639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440224/
https://www.ncbi.nlm.nih.gov/pubmed/32358340
http://dx.doi.org/10.1097/MD.0000000000018639

Ejemplares similares